|
1
|
PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1/2 and-MMP2 signaling.
|
Mol Cancer
|
2009
|
1.35
|
|
2
|
cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas.
|
J Clin Invest
|
2006
|
1.35
|
|
3
|
Mycoplasma hyorhinis infection in gastric carcinoma and its effects on the malignant phenotypes of gastric cancer cells.
|
BMC Gastroenterol
|
2010
|
1.14
|
|
4
|
Prognostic value of PRL-3 overexpression in early stages of colonic cancer.
|
Histopathology
|
2009
|
0.96
|
|
5
|
Applications of novel monoclonal antibodies specific for synuclein-gamma in evaluating its levels in sera and cancer tissues from colorectal cancer patients.
|
Cancer Lett
|
2008
|
0.92
|
|
6
|
Integrated analysis of gene expression profiles associated with response of platinum/paclitaxel-based treatment in epithelial ovarian cancer.
|
PLoS One
|
2012
|
0.92
|
|
7
|
CIAP2 inhibits anigen receptor signaling by targeting Bcl10 for degredation.
|
Cell Cycle
|
2006
|
0.86
|
|
8
|
Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen.
|
BMC Cancer
|
2010
|
0.86
|
|
9
|
Daxx is reciprocally regulated by Mdm2 and Hausp.
|
Biochem Biophys Res Commun
|
2010
|
0.86
|
|
10
|
Peptide mimic isolated by autoantibody reveals human arrest defective 1 overexpression is associated with poor prognosis for colon cancer patients.
|
Am J Pathol
|
2010
|
0.85
|
|
11
|
PRL-3 activates NF-κB signaling pathway by interacting with RAP1.
|
Biochem Biophys Res Commun
|
2012
|
0.85
|
|
12
|
Phosphatase of regenerating liver-3 directly interacts with integrin β1 and regulates its phosphorylation at tyrosine 783.
|
BMC Biochem
|
2012
|
0.84
|
|
13
|
Combined phenotype of 4 markers improves prognostic value of patients with colon cancer.
|
Am J Med Sci
|
2012
|
0.84
|
|
14
|
High level of serum AMBP is associated with poor response to paclitaxel-capecitabine chemotherapy in advanced gastric cancer patients.
|
Med Oncol
|
2013
|
0.84
|
|
15
|
Transcriptional regulation of PES1 expression by c-Jun in colon cancer.
|
PLoS One
|
2012
|
0.84
|
|
16
|
Phosphorylation of Daxx by ATM contributes to DNA damage-induced p53 activation.
|
PLoS One
|
2013
|
0.83
|
|
17
|
Mitochondrial apoptosis contributes to the anti-cancer effect of Smilax glabra Roxb.
|
Toxicol Lett
|
2011
|
0.82
|
|
18
|
N-α-acetyltransferase 10 protein inhibits apoptosis through RelA/p65-regulated MCL1 expression.
|
Carcinogenesis
|
2012
|
0.82
|
|
19
|
High NR2F2 transcript level is associated with increased survival and its expression inhibits TGF-β-dependent epithelial-mesenchymal transition in breast cancer.
|
Breast Cancer Res Treat
|
2014
|
0.82
|
|
20
|
Unconventional secretion of synuclein-γ promotes tumor cell invasion.
|
FEBS J
|
2014
|
0.81
|
|
21
|
PES1 regulates sensitivity of colorectal cancer cells to anticancer drugs.
|
Biochem Biophys Res Commun
|
2013
|
0.80
|
|
22
|
[Relation between Beta-2-glycoprotein I and hepatitis B virus surface antigen].
|
Zhonghua Gan Zang Bing Za Zhi
|
2002
|
0.80
|
|
23
|
Elevated serum synuclein-gamma in patients with gastrointestinal and esophageal carcinomas.
|
Hepatogastroenterology
|
2012
|
0.79
|
|
24
|
A possible receptor for beta 2 glycoprotein I on the membrane of hepatoma cell line smmc7721.
|
Chin Med J (Engl)
|
2003
|
0.79
|
|
25
|
N-α-acetyltransferase 10 protein is a negative regulator of 28S proteasome through interaction with PA28β.
|
FEBS Lett
|
2013
|
0.78
|
|
26
|
Inverse correlation between Naa10p and MMP-9 expression and the combined prognostic value in breast cancer patients.
|
Med Oncol
|
2013
|
0.78
|